Now, the Guerrilla Girls are having their first-ever commercial gallery exhibition at Hannah Traore Gallery in New York City, which recently opened and runs through March 29. Titled “Discrimi ...

The USA TODAY Sports Network has released its Tennessee high school girls basketball statewide ... Wendell Shepherd, The Commercial Appeal; Chris Van Tuyl, The Commercial Appeal.

Widely considered America’s first prima ballerina, Tallchief is being celebrated by New York City Ballet, where she was a Balanchine muse, in her centennial year. By Meryl Cates The ballerina ...

The CEO discussed the success of Dupixent and the remarkable achievement of over $13 billion in global sales in 2024, highlighting its commercial advantage and setting a milestone for Sanofi.

The girl was in the back seat of a brown Saturn Outlook when it was stolen on Thursday morning just after 6:00 a.m., according to the Rock Island Police Department. Officers were immediately ...

When she couldn’t find an adult dance program for experienced dancers in her Texas town, she reached out to one an hour away that allows her to take ballet classes with high school students ...

As the company faces criticism for its decision last year to not renew insurance policies for 72,000 property owners in California, State Farm has nixed plans to run a commercial during this year ...

Blessing Aoci has been reunited with her family, police said. A 4-year-old girl who was in the back seat of a vehicle when it was stolen early Thursday morning has been found safe following an ...

“My twin soul baby girl Chi turns 7 today!” Kim captioned the Jan. 15 post, which sees her posing with Chicago—who’s fittingly wearing a light pink top from her mom’s loungewear brand ...

Among other topics, Hudson discussed the success of Dupixent (dupilumab), highlighting that it has reached over $13bn in global sales, which affirms its commercial advantage and sets a milestone ...

Sanofi’s chief executive Paul Hudson discussed the success of Dupixent (dupilumab)and the remarkable achievement of over $13 billion in global sales in 2024, highlighting its commercial advantage and ...

Among other topics, Hudson discussed the success of Dupixent (dupilumab), highlighting that it has reached over $13bn in global sales, which affirms its commercial advantage and sets a milestone for ...